Chronic pain VR therapy market seen hitting $18.82B by 2030
The Business Research Company says the chronic pain virtual reality therapy market will grow from $6.09 billion in 2026 to $18.82 billion by 2030, driven by demand for drug-free pain relief and wider adoption of digital therapeutics. North America held the largest market share in 2025 as VR use expanded across healthcare settings.
Why it matters: - Chronic pain virtual reality therapy is moving from a niche digital tool toward a broader pain-management option as providers look for non-drug alternatives. - The market's projected jump to $18.82 billion by 2030 signals growing commercial interest in immersive therapies, telehealth integration and home-based care. - The trend matters for patients, providers and device makers because chronic pain is a long-running treatment challenge and opioid limits continue to reshape care choices.
What happened: - The Business Research Company released its Chronic Pain Virtual Reality Therapy Global Market Report 2026, covering market size, trends and forecasts for 2026-2035. - The report estimates the market will rise from $4.58 billion in 2025 to $6.09 billion in 2026. - The same report projects the market will reach $18.82 billion by 2030, implying a 32.6% CAGR from 2026 to 2030. - North America held the largest share of the chronic pain virtual reality therapy market in 2025.
The details: - The market's 2025-to-2026 increase reflects a 32.9% CAGR during the historical period cited in the report. - Growth drivers include a rising number of chronic pain sufferers, limits on opioid therapies and wider acceptance of digital therapeutic methods. - Additional tailwinds include growth in rehabilitation centers and the rising availability of consumer-friendly VR devices. - The report says future growth will be supported by stronger demand for pain relief methods that avoid pharmaceuticals. - The report also points to increased investment in digital therapeutics, more home-based pain therapy adoption and broader use of AI to tailor therapy experiences. - Stronger integration with telehealth services is another expected growth factor. - Trends expected during the period include more immersive VR distraction therapies, growth in VR-based cognitive behavioral programs and expansion of remote pain-management platforms. - The report also highlights more personalized VR content and a greater focus on non-drug pain control techniques. - Chronic pain virtual reality therapy uses immersive VR technology as a non-drug intervention to manage and reduce chronic pain. - The approach uses interactive virtual environments to divert attention from pain, lower pain perception, improve emotional well-being and support quality of life. - The therapy is meant to complement conventional pain management methods rather than replace them. - The report's regional coverage includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report also includes market attractiveness scoring, total addressable market analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics and updated graphics and tables.
Between the lines: - The report's growth assumptions point to a broader shift in chronic pain care toward digital, at-home and personalized treatment models. - The VA's rollout of about 3,500 VR headsets across more than 170 medical centers and outpatient clinics in July 2024 suggests public health systems are moving beyond pilot use. - That deployment tripled the availability of VR devices for therapeutic applications, underscoring growing institutional acceptance. - The market forecast also reflects an industry bet that VR can move from pain distraction to a repeatable clinical workflow tied to telehealth and rehabilitation.
What's next: - The Business Research Company expects adoption to keep expanding as digital therapeutics gain investment and VR content becomes more personalized. - Broader use of AI and telehealth should help determine whether chronic pain VR therapy scales from clinical settings into home-based care. - More regional growth is likely beyond North America as healthcare providers test non-drug pain management options. - More information is available in the full report and the free sample.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Healthy Living Europe
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.